James A. Kelley - Concepedia

Author

James A. Kelley

Also Known As

J A Kelley, J Kelley, J. A. KELLEY, J. A. Kelley, J. Kelley, J.A. Kelley, J.A. Kelleyx, JA Kelley, JAMES A. KELLEY, Jack A. Kelley

177

Publications

4.7K

Citations

H-Index

136

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Frederick National Laboratory for Cancer Research Center for Cancer Research Leidos (United States)

About

James A. Kelley is an author at National Cancer Institute specializing in medicine, pharmacology, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	52	2.3K
2	Natural Sciences	24	38	1.8K
3	Engineering	16	20	771
4	Health Sciences	3	3	84
5	Education	1	1	24

James A. Kelley

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Interleukin 6 Supports the Maintenance of p53 Tumor Suppressor Gene Promoter Methylation David R. Hodge, Benjamin Peng, James C. Cherry, Cancer Research	2005	222
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV Víctor E. Márquez, Christopher K. H. Tseng, Hiroaki Mitsuya, Journal of Medicinal Chemistry Medicinal Chemistry2',3'-Dideoxy Purine NucleosidesBiochemistryFluorine-containing AnaloguesMedicine	1990	211
Nitroxide-catalyzed oxidation of alcohols using m-chloroperbenzoic acid. New method James A. Cella, James A. Kelley, Edward F. Kenehan The Journal of Organic Chemistry HalogenationChemical EngineeringEngineeringChemical AnalysisM-chloroperbenzoic Acid	1975	159
Reactive species involved in the regioselective photooxidation of heptamethine cyanines Roger R. Nani, James A. Kelley, Joseph Ivanic, Chemical Science	2015	156
The conversion of 2-β-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties David A. Cooney, Hiremagalur N. Jayaram, Gulilat Gebeyehu, Biochemical Pharmacology Medicinal ChemistryBiochemistryNatural SciencesBiocatalysisMedicine	1982	121
2',3'-Dideoxy-2'-fluoro-ara-a. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV) Víctor E. Márquez, Christopher K. H. Tseng, James A. Kelley, Biochemical Pharmacology Nucleic Acid ChemistryBiochemistryMedicineAcid-stable PurineOligonucleotide	1987	113
Conversion of 2-β-D-ribofuranosylselenazole-4-carboxamide to an analogue of nad with potent imp dehydrogenase-inhibitory properties Hiremagalur N. Jayaram, Gurpreet S. Ahluwalia, Robert L. Dion, Biochemical Pharmacology Medicinal ChemistryBiochemistryNatural SciencesBiocatalysisMedicine	1983	104
Microarray Analysis of Epigenetic Silencing of Gene Expression in the KAS-6/1 Multiple Myeloma Cell Line Celine Pompéia, David R. Hodge, Christoph Plass, Cancer Research Histone ModificationsMixed-phenotype Acute LeukemiaGeneticsDna MethylationEpigenetic Change	2004	96
Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells Tsipi Ben-Kasus, Zvi Ben‐Zvi, Víctor E. Márquez, Biochemical Pharmacology BiochemistryGenitourinary CancerMetabolic ActivationMedicineEpigenetic Change	2005	92
Ribavirin, tiazofurin, and selenazofurin: mononucleotides and nicotinamide adenine dinucleotide analogs. Synthesis, structure, and interactions with IMP dehydrogenase Gulilat Gebeyehu, Víctor E. Márquez, Anne Van Cott, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiosynthesisNucleic Acid ChemistryBiochemistry	1985	91

Page 1